ResMed Inc.

In the first quarter of fiscal year 2024, ResMed Inc. had robust results across its business segments, with significant double-digit growth in masks, SaaS, and devices. Notably, the masks and accessories business achieved a remarkable 21% year-over-year growth, even in a competitive market. ResMed’s emphasis on patient engagement and consumers’ proactive approach to respiratory health has boosted demand, particularly in non-reimbursed markets, due to increased awareness following the COVID-19 pandemic. ResMed is investing in alternative therapies to cater to patients not adhering to primary PAP (Positive Airway Pressure) therapy, addressing a substantial underserved patient population. The company’s 32% year-over-year growth in SaaS business further solidifies its global leadership in healthcare, providing innovative digital health solutions and patient-centered care in a dynamic healthcare landscape. Moreover, ResMed’s strategic initiatives are underpinned by its extensive global reach. The company is progressively expanding its patient funnel by leveraging marketing and digital outreach programs to educate consumers about the importance of respiratory health and sleep.